STAT3 and cancer: Comparable results has been reported by ( Matsuzaki et al., 2018), patients with high grade tumor , are patients with high STAT3 tumor and have a significantly higher risk of both disease progression (p = 0.008) and cancer-specific mortality (p = 0.008).